Executive team does not have clear strategy. Consistently under capitalized. Can't afford to develop products effectively. Stock options rarely offered and no path to profitability. Bonus payments are 2 years behind(!). Little prospects for career growth at Director and above. High performance is not rewarded. Medical plan was a strong benefit but was significantly reduced and costs to employees increased.